Rabbit Anti-MS4A1 DNA-encoded mAb (CBFYC-0050), pVAX1 (DMAb-3146-FY)

DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics. This product is the plasmid containing an encoded Rabbit Anti-MS4A1 DMAb (CBFYC-0050) sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

Datasheet   Add to Cart


  • Target
  • MS4A1
  • Target Species
  • Human
  • DMAb Host
  • Rabbit
  • DMAb Immunogen
  • Human CD20 Transfected CHO Cells
  • DMAb Cross Reactivity
  • Human
  • DMAb Isotype
  • IgG
  • DMAb Clone
  • CBFYC-0050
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.


  • Entrez Gene ID
  • 931

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry



Call us at:

Online Inquiry

For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.

Key Updates

Receive our latest news and insights.